Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mar Drugs ; 11(8): 3091-108, 2013 Aug 21.
Article in English | MEDLINE | ID: mdl-23966039

ABSTRACT

Cyanobacteria produce a range of secondary metabolites, one being the neurotoxic non-protein amino acid ß-N-methylamino-L-alanine (BMAA), proposed to be a causative agent of human neurodegeneration. As for most cyanotoxins, the function of BMAA in cyanobacteria is unknown. Here, we examined the effects of BMAA on the physiology of the filamentous nitrogen-fixing cyanobacterium Nostoc sp. PCC 7120. Our data show that exogenously applied BMAA rapidly inhibits nitrogenase activity (acetylene reduction assay), even at micromolar concentrations, and that the inhibition was considerably more severe than that induced by combined nitrogen sources and most other amino acids. BMAA also caused growth arrest and massive cellular glycogen accumulation, as observed by electron microscopy. With nitrogen fixation being a process highly sensitive to oxygen species we propose that the BMAA effects found here may be related to the production of reactive oxygen species, as reported for other organisms.


Subject(s)
Amino Acids, Diamino/metabolism , Nitrogen Fixation/physiology , Nostoc/metabolism , Reactive Oxygen Species/metabolism , Amino Acids/metabolism , Amino Acids, Diamino/administration & dosage , Cyanobacteria Toxins , Glycogen/metabolism , Microscopy, Electron , Nitrogenase/metabolism
2.
Proc Natl Acad Sci U S A ; 107(20): 9252-7, 2010 May 18.
Article in English | MEDLINE | ID: mdl-20439734

ABSTRACT

beta-methylamino-L-alanine (BMAA), a neurotoxic nonprotein amino acid produced by most cyanobacteria, has been proposed to be the causative agent of devastating neurodegenerative diseases on the island of Guam in the Pacific Ocean. Because cyanobacteria are widespread globally, we hypothesized that BMAA might occur and bioaccumulate in other ecosystems. Here we demonstrate, based on a recently developed extraction and HPLC-MS/MS method and long-term monitoring of BMAA in cyanobacterial populations of a temperate aquatic ecosystem (Baltic Sea, 2007-2008), that BMAA is biosynthesized by cyanobacterial genera dominating the massive surface blooms of this water body. BMAA also was found at higher concentrations in organisms of higher trophic levels that directly or indirectly feed on cyanobacteria, such as zooplankton and various vertebrates (fish) and invertebrates (mussels, oysters). Pelagic and benthic fish species used for human consumption were included. The highest BMAA levels were detected in the muscle and brain of bottom-dwelling fishes. The discovery of regular biosynthesis of the neurotoxin BMAA in a large temperate aquatic ecosystem combined with its possible transfer and bioaccumulation within major food webs, some ending in human consumption, is alarming and requires attention.


Subject(s)
Amino Acids, Diamino/pharmacokinetics , Cyanobacteria/chemistry , Environmental Exposure , Food Chain , Marine Toxins/pharmacokinetics , Neurotoxins/pharmacokinetics , Amino Acids, Diamino/biosynthesis , Amino Acids, Diamino/metabolism , Animals , Chromatography, High Pressure Liquid , Cyanobacteria Toxins , Fishes/metabolism , Humans , Invertebrates/chemistry , Marine Toxins/biosynthesis , Marine Toxins/metabolism , Neurotoxins/biosynthesis , Neurotoxins/metabolism , North Sea , Sweden , Tandem Mass Spectrometry , Zooplankton/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...